Begin main content

About CADTH Scientific Advice

The CADTH Scientific Advice Program is a voluntary, non-binding, and confidential fee-for-service consultation. Through this Program, pharmaceutical companies are provided with advice on their early drug development plans from a Canadian health technology assessment perspective.

What’s New

The CADTH Scientific Advice Program now offers a new level of responsiveness and flexibility to better meet the needs of the pharmaceutical industry. In the fast-paced and demanding environment of drug development, a one-size-fits-all approach simply isn’t optimal. Applicants may now inquire about:

  • customized timelines
  • more timely advice for smaller requests
  • obtaining advice at multiple time points along their early drug development plans.

We welcome your inquiries. Please contact us at to see how we can work with you to address your needs.

Note: We are currently revising our Scientific Advice web pages. Please stay tuned for updates.